
In the last five years, Covidien has doubled R&D investments and introduced more than 100 new products. The Company’s goal is to continue to increase R&D spending to 5%-to-6% of sales, as it launches more than 50 products during the next two years. The opening of the Innovation Center in Boulder will be a catalyst for the expansion of R&D capabilities, spurring collaboration and creativity, while decreasing product time-to-market."
Other March FOCUS content includes:
From CBSA President Holli Riebel - Page 1
Medical Device Liability Protection - Page 3
Biotech Pharma Symposium - Page 4
Upcoming Events - Page 5
Link to the March FOCUS Newsletter pdf
No comments:
Post a Comment